Minimal residual disease in patients with diffuse large B-cell lymphoma undergoing autologous stem cell transplantationReid W. Merryman, Philippe Armand, Oreofe O. Odejide et al.|Blood Advances|2022Cited by 19
Interim Positron Emission Tomography During Frontline Chemoimmunotherapy for Follicular LymphomaReid W. Merryman, Heather A. Jacene, Laure Michaud et al.|HemaSphere|2023Cited by 11
Prognostic Value of Circulating Tumor DNA (ctDNA) in Autologous Stem Cell Graft and Post-Transplant Plasma Samples Among Patients with Diffuse Large B-Cell LymphomaReid W. Merryman, Philippe Armand, Robert Redd et al.|Blood|2020Cited by 9
Interim Positron Emission Tomography (iPET) Assessed Using Deauville Score for Patients with Follicular Lymphoma Receiving First-Line ChemoimmunotherapyReid W. Merryman, Heather A. Jacene, Gabriela Spilberg et al.|Blood|2020Cited by 1
Outpatient Versus Inpatient Management of Grade 1 Cytokine Release Syndrome in Follicular Lymphoma Patients Receiving Bispecific Antibodies: A Cubic StudyLynnette Henshaw, Jennifer L. Crombie, Sairah Ahmed et al.|Transplantation and Cellular Therapy|2026Cited by 0